Today: 19 July 2026
Browse Category

NASDAQ:MRNA 28 September 2025 - 19 October 2025

For live price, interactive charts, financials and the latest market data, visit Google Finance.
Wall Street Feels the Heat (and Thrill): Fed Cuts, Tariffs & Mega-Mergers Set NYSE Buzz

Stock Market Today 19.10.2025

ENDEDLive coverage has endedEnded: October 21, 2025, 6:00 AM EDT IonQ vs Nvidia: Which AI Stock Has the Better Long-Term Upside? October 20, 2025, 5:58 AM EDT. IonQ offers long-term AI potential through quantum computing, with room-temperature operation and growing partnerships such as Oak Ridge National Laboratory. Its recent Q3 results showed revenue up 102% YoY to $12.4 million and $63.5 million in new bookings, but the firm remains unprofitable, posting a net loss of $52.5 million as it spends on R&D and pursues growth, including the Qubitekk acquisition to build a networked quantum ecosystem. Nvidia remains the more established
19 October 2025
···········
Moderna’s Wild Ride: Vaccine Hopes Fuel Stock Pop Amid “One-Hit Wonder” Fears

Moderna’s Wild Ride: Vaccine Hopes Fuel Stock Pop Amid “One-Hit Wonder” Fears

Moderna’s stock is back in the spotlight after a turbulent week of news that sent the Nasdaq-listed shares swinging. On Wednesday, MRNA jumped over 5%, climbing to around $27.7 by market close marketbeat.com. The mini-rally came amid a flurry of developments – from upbeat trial data on a new cancer vaccine to analysts debating whether Moderna’s future is bright or bleak. Even after the pop, however, Moderna’s stock is a shadow of its former self: shares have cratered roughly 80% below last year’s levels marketbeat.com and are down one-third in 2025 alone. The once high-flying biotech – which briefly surpassed $170 billion in market value during the COVID vaccine euphoria – is now hovering near multi-year lows, with a market cap around $10–11 billion ts2.tech.
16 October 2025
··
Moderna, Inc. (MRNA) Stock Update – Oct 8 2025: Will the mRNA Trailblazer Bounce Back or Sink Further?

Moderna, Inc. (MRNA) Stock Update – Oct 8 2025: Will the mRNA Trailblazer Bounce Back or Sink Further?

Moderna’s stock was a market darling during the pandemic but has suffered a long decline. On Oct 7 2025, the stock closed at $27.34, down roughly 0.7% from $27.54 on the prior sessionstockinvest.us. Technical analysts at Stockinvest.us noted the shares were near the upper part of a wide falling trend and predicted a possible trading range of $26.40–$28.73 on Oct 8, with longer‑term support around $26 and resistance near $31stockinvest.us. While short‑term signals were positive, they cautioned that the overall downward trend remainsstockinvest.us.
8 October 2025
··
Billion-Dollar AI Bets and Biotech Breakthroughs: Top Tech News (Sept 27–28, 2025)

Billion-Dollar AI Bets and Biotech Breakthroughs: Top Tech News (Sept 27–28, 2025)

Nvidia–OpenAI Partnership: Nvidia announced a landmark collaboration with OpenAI to deploy at least 10 gigawatts of AI computing power. Under the plan, Nvidia will invest up to $100 billion as each gigawatt of NVIDIA systems is deployed nvidianews.nvidia.com. The first 1 GW is slated for late 2026 on Nvidia’s new “Vera Rubin” supercomputer. CEO Jensen Huang said this marks “the next leap forward — deploying 10 gigawatts to power the next era of intelligence” nvidianews.nvidia.com. OpenAI’s Sam Altman emphasized that “everything starts with compute,” and the new chips will fuel AI breakthroughs. This deal comes amid massive demand for AI chips – Nvidia will continue to serve all customers, but the investment ties OpenAI and Nvidia closely together nvidianews.nvidia.com nvidianews.nvidia.com.
28 September 2025
·········
1 2 3 4
Go toTop